Butyrate, also known as butyric acid, is an emerging treatment option for a wide range of health conditions, particularly gastrointestinal disorders and GI-associated neurological conditions like autism spectrum disorder (ASD).
Ulcerative colitis (UC) is an inflammatory bowel disease (IBD) which causes patients to experience a higher than normal number of daily stools, bloody or disrupted stools, diarrhea, pain, weight loss, inflammation, and bloating.
For patients with ulcerative colitis, developing an effective management strategy can be a major challenge. Symptoms vary widely between patients, and many of the most common therapeutics—including aminosalicylates.
New research is shedding light on the links between Crohn’s disease treatment and microbiome health, potentially opening up the door to better treatment options that provide more complete and durable relief of symptoms.
Compelling evidence has begun to emerge in support of modern dietary interventions for those who seek to alleviate IBD symptoms noninvasively, including the FODMAP diet and targeted nutraceutical interventions.
As the body of research highlighting potential health benefits of butyric acid grows, both researchers and health practitioners are recommending bioavailable butyric acid supplements for patients with a wide variety of health conditions.
The use of antibiotics is all too common in modern medicine, with risks that are becoming increasingly evident. While they are literally life-saving in many instances, they may also lead to antibiotic-induced colitis in some patients.
In recent years, researchers have been increasingly recognizing the gut-brain axis as a potential target for intervention in a broad range of challenging medical conditions, including neurological, intestinal, and psychiatric disorders.